Abstract

As part of a study exploring the use of oral diazepam to reduce carbon dioxide production and extend survival in a disabled submarine, intranasal flumazenil was used repeatedly over 48 hours to intermittently reverse benzodiazepine-induced sedation in six adult male subjects. Previous reports of intranasal flumazenil have been limited to pediatric pa-tients. Here we report the time course of administration of intranasal flumazenil and its effects on adult subjects, in whom flumazenil was given during sedation/reversal/re-sedation cycles. Sedation scores increased with flumazenil administra-tion in 24 of the 30 cycles, and in 100% of cases when subjects were at deeper levels of sedation.

Highlights

  • The U.S Food & Drug Administration has only approved intravenous administration of flumazenil, there are reports in the pediatric literature of successful intranasal [1, 2] and rectal administration [3, 4] of this competitive benzodiazepine antagonist

  • After the 30 intranasal administrations, OAA/S scores increased in twenty-four cases,and they remained the same in six cases; when subjects were at deeper levels of sedation (OAA/S scores less than 4), these scores increased in 100% of cases after flumazenil administration

  • At the 24-hour telephone follow up, the subjects still reported symptoms of sedation, while at the 72hour telephone follow up they reported that they were back to normal condition and activities. This is the first report in the medical literature of the use of intranasal flumazenil to reverse sedation in healthy adult humans

Read more

Summary

Introduction

The U.S Food & Drug Administration has only approved intravenous administration of flumazenil, there are reports in the pediatric literature of successful intranasal [1, 2] and rectal administration [3, 4] of this competitive benzodiazepine antagonist. There is no report of intranasal flumazenil administration in adults in the medical literature, only an internet summary of a graduate student thesis [6]. As part of a study exploring the use of a benzodiazepine (diazepam) to reduce carbon dioxide production and extend survival in a disabled submarine, intranasal flumazenil was used repeatedly over 48 hours to intermittently reverse sedation in adult subjects [7]. We report the time course of the administration of intranasal flumazenil and its effects on young healthy adults

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.